Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Barry Kapik"'
Autor:
José, Cunha-Vaz, Paul, Ashton, Raymond, Iezzi, Peter, Campochiaro, Pravin U, Dugel, Frank G, Holz, Michel, Weber, Ronald P, Danis, Baruch D, Kuppermann, Clare, Bailey, Kathleen, Billman, Barry, Kapik, Frances, Kane, Ken, Green, Y, Yang
Publikováno v:
Ophthalmology. 121(10)
To present the safety and efficacy of intravitreal implants releasing 0.2 μg/day fluocinolone acetonide (FAc) in patients with chronic versus nonchronic diabetic macular edema (DME). To assess ocular characteristics, anatomic changes, and re-treatme
Autor:
Miguel Busquets, Barry Kapik, Ken Green, Quan Dong Nguyen, Leonard Feiner, Thomas A. Ciulla, David M. Brown, Peter A. Campochiaro, Gulnar Hafiz, Kane Frances Elizabeth, Nelson R. Sabates, Steven M. Bloom, Kathleen Billman
Publikováno v:
Ophthalmology. 120(3)
Purpose To compare aqueous levels of fluocinolone acetonide (FAc) after administration of FAc inserts or FAc implants (Retisert; Bausch & Lomb, Rochester, NY). Design Comparison of pharmacokinetics from 2 prospective, interventional, clinical trials.
Autor:
Kane Frances Elizabeth, Elias Reichel, Ken Green, David M. Brown, Sanford Chen, José M. Ruiz-Moreno, David S. Boyer, Peter A. Campochiaro, Clare Bailey, Andrew Pearson, Bruce R. Garretson, Kathleen Billman, Seenu M. Hariprasad, Gisèle Soubrane, Barry Kapik, Amod Gupta
Publikováno v:
Ophthalmology. 119(10)
Objective To assess long-term efficacy and safety of intravitreal inserts releasing 0.2 μg/d (low dose) or 0.5 μg/d (high dose) fluocinolone acetonide (FAc) in patients with diabetic macular edema (DME). Design Two randomized, sham injection-contro
Autor:
Peter A, Campochiaro, Gulnar, Hafiz, Syed Mahmood, Shah, Steven, Bloom, David M, Brown, Miguel, Busquets, Thomas, Ciulla, Leonard, Feiner, Nelson, Sabates, Kathleen, Billman, Barry, Kapik, Ken, Green, Frances, Kane, James, Hays
Publikováno v:
Ophthalmology. 117(7)
Purpose To compare Iluvien intravitreal inserts that release 0.2 or 0.5 μg/day of fluocinolone acetonide (FA) in patients with diabetic macular edema (DME). Design Prospective, randomized, interventional, multicenter clinical trial. Participants We
Autor:
L. Duarte, Andrew Pearson, John R. Gonder, Kathleen Billman, Kane Frances Elizabeth, David S. Boyer, Steven A. Madreperla, Frank G. Holz, Barry Kapik, Peter A. Campochiaro, Michael J. Tolentino, Amod Gupta, Thomas A. Ciulla, David M. Brown
Publikováno v:
Ophthalmology. 118:626-635.e2
Objective To assess the efficacy and safety of intravitreal inserts releasing 0.2 μg/day (low dose) or 0.5 μg/day (high dose) fluocinolone acetonide (FA) in patients with diabetic macular edema (DME). Design Two parallel, prospective, randomized, s